Edition:
United Kingdom

Haemonetics Corp (HAE.N)

HAE.N on New York Stock Exchange

65.83USD
22 Jan 2018
Change (% chg)

$1.44 (+2.24%)
Prev Close
$64.39
Open
$64.53
Day's High
$65.87
Day's Low
$64.25
Volume
69,892
Avg. Vol
101,190
52-wk High
$65.87
52-wk Low
$36.44

Latest Key Developments (Source: Significant Developments)

Haemonetics says ‍on Nov 1, board approved complexity reduction initiative program
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Haemonetics Corp ::Haemonetics - ‍on Nov 1, board approved complexity reduction initiative program, which includes a reduction of headcount and operating costs.Haemonetics Corp- ‍expect savings from program of about $80 million on an annualized basis once program is completed​.Haemonetics says expects to incur between $50 million and $60 million to streamline organizational structure - SEC filing.  Full Article

Haemonetics Corp Q1 adjusted earnings per share $0.25
Monday, 1 Aug 2016 

Haemonetics Corp : Q1 fiscal 2017 revenue of $210.0 million; Q1 earnings per share $0.20; Q1 adjusted earnings per share $0.25 . Q1 earnings per share view $0.28, revenue view $205.4 million -- Thomson Reuters I/B/E/S . Company affirmed its fiscal 2017 guidance .Full-year 2017 earnings per share view $1.45, revenue view $865.6 million -- Thomson Reuters I/B/E/S.  Full Article

Haemonetics appoints Bill Burke CFO
Monday, 1 Aug 2016 

Haemonetics Corp : Haemonetics appoints Bill Burke CFO .Burke will join company from Medtronic Inc.  Full Article

Haemonetics plans repositioning organization, reduce number of employees
Tuesday, 10 May 2016 

Haemonetics Corp : On may 6, 2016, co committed to a plan for repositioning organization and cost structure; this involves reduction in number of employees . Estimate actions will result in total pre-tax expenses of about $26 million, nearly all of charges will result in future cash outlays .Estimate that co will record substantially all these charges during fiscal 2017 - sec filing.  Full Article

Haemonetics Corp announces Christopher Simon as CEO
Monday, 9 May 2016 

Haemonetics Corp : Haemonetics corporation announces Christopher Simon as president and chief executive officer .Chris currently serves as a senior partner of Mckinsey & Company.  Full Article

Haemonetics Corp sees FY 2017 adjusted earnings per share $1.40-$1.50
Monday, 9 May 2016 

Haemonetics Corp : Haemonetics provides fiscal 2017 guidance . Sees FY 2017 adjusted earnings per share $1.40-$1.50 . FY2017 earnings per share view $1.55, revenue view $911.3 million -- Thomson Reuters I/B/E/S .Sees FY 2017 revenue $850 million to $875 million.  Full Article

Haemonetics Corp announces CFO's Retirement
Thursday, 14 Apr 2016 

Haemonetics Corp:Christopher Lindop , Chief Financial Officer and Executive Vice President, Business Development has announced retirement.Company announced it will immediately begin a search for Lindop's successor.  Full Article

BRIEF-Haemonetics says ‍on Nov 1, board approved complexity reduction initiative program

* Haemonetics - ‍on Nov 1, board approved complexity reduction initiative program, which includes a reduction of headcount and operating costs